Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials

OBJECTIVE: To analyze the efficacy and safety of three novel hypoglycemic agents, glucagon-like peptidyl-1 receptor agonists, dipeptidyl peptidase-4 inhibitors (DPP-4i), and sodium-glucose cotransporter two inhibitors (SGLT2i) in type 2 diabetes mellitus (T2DM) patients with severe chronic kidney di...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yijun, Hu, Ying, Huyan, Xiaoyuan, Chen, Kang, Li, Bing, Gu, Weijun, Mu, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637657/
https://www.ncbi.nlm.nih.gov/pubmed/36353233
http://dx.doi.org/10.3389/fendo.2022.1003263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637657/
https://www.ncbi.nlm.nih.gov/pubmed/36353233
http://dx.doi.org/10.3389/fendo.2022.1003263

Ejemplares similares